期刊文献+

慢性髓系白血病急变期与急性白血病免疫表型的比较研究

Comparative Study of the Immunophenotype of Chronic Myeloid Leukemia in Blast Crisis and Acute Leukemia
下载PDF
导出
摘要 目的比较慢性髓系白血病急变期(CML-BC)与急性白血病(AL)的免疫表型特征。方法采用一组单克隆抗体和四色流式细胞术对58例成人CML-BC及同期420例AL患者骨髓标本进行免疫表型分析。结果58例CML-BC中,CML-AML占77.6%,CML-ALL占13.8%,CML-MAL(混合性白血病)占5.2%;AL中,AML占66.2%,ALL占32.9%,MAL占1.0%。CML-AML中,CD7及CD34表达高于AML;CML-BC和CML-AML中CD7与CD34共阳性表达分别高于AL和AML(P<0.05)。276例AML中,纯型占62.3%,变异型占37.7%;130例ALL中,纯型占44.6%,变异型占55.4%;42例CML-AML中,纯型占59.5%,变异型占40.5%;8例CML-ALL中,纯型与变异型各占50.0%。结论CML-BC中干祖细胞阶段的抗原较AL高表达,变异型CML-BC与AL比例相当。 Objective To compare the immunophenotypic features of chronic myeloid leukemia (CML) in blast crisis and acute leukemia(AL). Methods Immunophenotypic analysis was performed using a panel of monoclonal antibodies and four-color immunofluorescence staining methods of flow cytometry in 58 patients with CML-BCLL and 420 patients with AL during the same period. Results 77.6% of the CML-BC patients were AML transformation, 13.8% was ALL transformation and 5.2% was MAL (mixed lineage acute leukemia) transformation. In AL, 66k 2 % of the patients were AML, 32.9 % was ALL and 1.0 % was MAL. In CML-AML, CD34 and CD7 positivity was higher than that in AL. Coexpression of CD7 and CD34 was more frequent in CML-BC and CML-AML than that in AL and AML(P 〈 0.05) respectively. In 276 AMLcases, the pure phenotype accounted for 62.3 % and variant type 37.7 %. In 130 ALLcases, the pure phenotype accounted for 44.6 % and variant type 55.4 %. The pure and variant type accounted for 59.5 % and 40.5 % in 42 cases of CML-AML, 50.0% and 50.0% in 8 cases of CML-ALL. Conclusions The present study suggests that the hematopoietic precursor antigen is more frequent in CML-BC than that in AL. The variant type is proper in CML-BC and AL.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2006年第2期240-243,258,共5页 Suzhou University Journal of Medical Science
基金 江苏省135医学重点人才基金资助项目(RC2002044)
关键词 慢性髓系白血病急变 急性白血病 免疫分型 chronic myeloid leukemia in blast crisis acute leukemia immunophenotype
  • 相关文献

参考文献16

  • 1Jaffe E,Harris N,Stein H,et al.Pathology and genetics of tumours of haematopoietic and lymphoid tissues.World Health Organization Classification of Tumours[M].Lyon,France:IARC Press
  • 2Pelloso L,Baiocchi O,Chauffaille M,et al.Megakaryocytic blast crisis as a first presentation of chronic myeloid leukemia[J].Eur J Haematol,2002,69:58-61.
  • 3Murase T,Suzuki R,Tashiro K,et al.Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor[J].Int J Hematol,1999,69:89-91.
  • 4高云阁,李艳,赵应,郝佳,张军学.慢性粒细胞白血病急非淋变与急淋变的临床对比分析[J].中国综合临床,2004,20(4):305-307. 被引量:3
  • 5Wadhwa J,Szydlo R M,Apperley J F,et al.Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia[J].Blood,2002,99:2304-2309.
  • 6Khalidi H,Brynes R,Medeiros L,et al.The immunophenotype of blast transformation of chronic myelogenous leukemia:a high frequency of mixed lineage phenotype in "lymphoid" blasts and a comparison of morphologic,immunophenotypic,and molecular findings[J].Mod Pathol,1998,11:1211-1221.
  • 7Favre G,Passweg J,Hoffmann T,et al.Immunophenotype of blast crisis in chronic myeloid leukemia[J].Schweiz Med Wochenschr,1998,128:1624-1626.
  • 8Lopez-Karpovitch X,Cardenas R,Piedras J.Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia[J].Rev Invest Clin,1997,49:31-36.
  • 9Banavali S,Silvestri F,Hulette B,et al.Expression of hematopoietic progenitor cell associated antigen CD34 in chronic myeloid leukemia[J].Leuk Res,1991,15:603-608.
  • 10Normann AP,Egeland T,Madshus I H,et al.CD7 expression by CD34+ cells in CML patients,of prognostic significance?[J].Eur J Haematol,2003,71:266-275.

二级参考文献17

  • 1刘征辉,张学光,夏学鸣,郑列琳,陆定伟,薛永权,阮长耿.表达CD_7抗原的急性髓细胞白血病[J].中华血液学杂志,1996,17(2):84-84. 被引量:9
  • 2张之南 忱悌.血液病诊断及疗效标准(第2版)[M].北京:科学出版社,1999.270-271.
  • 3刘征辉,中华血液学杂志,1996年,17卷,84页
  • 4Yen CC, Liu JH, Wang WS, et al. Immunophenotypic and genotypic characteristics of chronic myelogenous leukemia in blast crisis[ J].Zhonghua Yi Xue Za Zhi(Tai pei) ,2000,63(11) :785-791.
  • 5Yamaguchi H, Inokuchi K, Sakuma Y, et al. Mutation of the P 51/P 63 gene is associated with blastic crisis in chronic myelogenoua leukemia[ J]. Leukemia,2001,15 ( 11 ): 1729-1734.
  • 6Gaiger A, Henn T, C eissler K, et al. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression[ J]. Blood, 1995,15:86(6):2371-2378.
  • 7Fenaux P. The clinical significance of mutation of the P53 tumor auppresser gene in hematological malignancies[ J]. Br J Haematol,1997,98(1) :502-511.
  • 8Carapeti M, Soede B A, Hochhaus A, et al. Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia[ J]. Leukemia,1997,11 (2) :1005-1008.
  • 9Handa H, Hegde UP, Kotelnikov VW, et al. Bcl-2 and c-myc exqression,cell cycle kinetics and apoptosis during the progression of cbronic myeloid leukemia from diagnosis to blast crisis [ J ]. Leu Res,1997,21 ( 1 ) :479-489.
  • 10Derderian PM,Kantarjian HM,Talpaz M,et al. Chronic myelogenous leukemia in the lymphoid blastic phase:characteristic,treatment response,and prognosis[ J]. Am J Med,1993 ,94(1) :69-74.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部